These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Scientific report: highlights of 25th ICAR, 16-19 April 2012, Sapporo, Japan. Hodge AV Antivir Chem Chemother; 2012 Sep; 23(1):19-33. PubMed ID: 22976587 [TBL] [Abstract][Full Text] [Related]
9. Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA. Vere Hodge RA Antivir Chem Chemother; 2018; 26():2040206618783924. PubMed ID: 29954186 [TBL] [Abstract][Full Text] [Related]
10. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments. Abdurrahman L; Fang X; Zhang Y Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374 [TBL] [Abstract][Full Text] [Related]
11. International society for antiviral research - 23rd international conference. Mason VL IDrugs; 2010 Jun; 13(6):363-5. PubMed ID: 20506054 [TBL] [Abstract][Full Text] [Related]
12. Highlights of the 30th International Conference on Antiviral Research. Andrei G; Carter K; Janeba Z; Sampath A; Schang LM; Tarbet EB; Vere Hodge RA; Bray M; Esté JA Antiviral Res; 2017 Sep; 145():184-196. PubMed ID: 28774800 [TBL] [Abstract][Full Text] [Related]
13. Antiviral Efficacy of Molnupiravir for COVID-19 Treatment. Bai Y; Shen M; Zhang L Viruses; 2022 Apr; 14(4):. PubMed ID: 35458493 [TBL] [Abstract][Full Text] [Related]
14. Current Perspective of Antiviral Strategies against COVID-19. Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102 [TBL] [Abstract][Full Text] [Related]
15. Metal-based complexes against SARS-CoV-2. Ioannou K; Vlasiou MC Biometals; 2022 Aug; 35(4):639-652. PubMed ID: 35332435 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3- Stalinskaya AL; Martynenko NV; Shulgau ZT; Shustov AV; Keyer VV; Kulakov IV Molecules; 2022 Jun; 27(12):. PubMed ID: 35744830 [TBL] [Abstract][Full Text] [Related]
17. COVID-19: Progress in diagnostics, therapy and vaccination. Liu X; Liu C; Liu G; Luo W; Xia N Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022 [TBL] [Abstract][Full Text] [Related]
18. Discovering small-molecule therapeutics against SARS-CoV-2. Tiwari V; Beer JC; Sankaranarayanan NV; Swanson-Mungerson M; Desai UR Drug Discov Today; 2020 Aug; 25(8):1535-1544. PubMed ID: 32574699 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic. Bhandari R; Khanna G; Kuhad A Eur J Pharmacol; 2021 Jan; 890():173643. PubMed ID: 33065092 [TBL] [Abstract][Full Text] [Related]
20. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]